Literature DB >> 2166828

Functional diversity in vascular endothelial cells: role in coxsackievirus tropism.

S A Huber1, C Haisch, P A Lodge.   

Abstract

Six plaque-purified virus isolates were obtained from liver and heart tissues of a DBA/2 mouse infected 7 days earlier with 10(4) PFU of coxsackievirus group B type 3. Each virus isolate was assayed in vitro for infectivity to vascular endothelial cells (VEC) of the liver, lungs, and heart. Both the percentage of VEC infected and the mean progeny PFU produced per infected VEC were determined. Virus isolates from the heart showed greater infectivity and replication in heart VEC than in VEC derived from either the liver or lungs. Similarly, virus isolated from the liver preferentially infected liver VEC. Virus receptor expression varied between VEC populations, as demonstrated by binding studies with a [35S]methionine-radiolabeled heart virus and by enzyme-linked immunoadsorption assay studies with a monoclonal antibody to the coxsackievirus group B type 3 receptor on heart tissue. Finally, the heart and liver virus isolates were injected (10(4) PFU) intraperitoneally into BALB/c mice. After 7 days, the animals were sacrificed, and the hearts, livers, and lungs were evaluated for tissue injury and virus concentrations. Viruses originally isolated from the heart preferentially infected the heart when reinjected into animals and caused severe myocarditis. Viruses originally derived from the liver most consistently reinfected the liver, although significant virus concentrations were also detected in the heart. The liver virus isolates, however, were incapable of causing myocarditis. Thus, selective tropism of viruses for particular organs in vivo corresponds to the ability of these isolates to infect VEC in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166828      PMCID: PMC247922          DOI: 10.1128/JVI.64.9.4516-4522.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  Current views on the etiology of insulin-dependent diabetes mellitus.

Authors:  J E Craighead
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

2.  Patho-anatomical findings in a case of mumps with pancreatitis, myocarditis, orchitis, epididymitis and seminal vesiculitis.

Authors:  K Boström
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1968

3.  Postinfectious and postvaccinial encephalomyelitis.

Authors:  S Sriram; L Steinman
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

4.  Virus infection of endothelial cells.

Authors:  H M Friedman; E J Macarak; R R MacGregor; J Wolfe; N A Kefalides
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

5.  Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.

Authors:  K J Reagan; B Goldberg; R L Crowell
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

6.  Acute fulminant myoglobinuric polymyositis with picornavirus-like crystals.

Authors:  Y Fukuyama; T Ando; J Yokota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

7.  Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.

Authors:  R L Crowell; A K Field; W A Schleif; W L Long; R J Colonno; J E Mapoles; E A Emini
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

8.  Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo.

Authors:  R Auerbach; W C Lu; E Pardon; F Gumkowski; G Kaminska; M Kaminski
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

9.  Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.

Authors:  S A Huber; P A Lodge
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

10.  Stereological analysis of the guinea pig pancreas. I. Analytical model and quantitative description of nonstimulated pancreatic exocrine cells.

Authors:  R P Bolender
Journal:  J Cell Biol       Date:  1974-05       Impact factor: 10.539

View more
  17 in total

1.  Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.

Authors:  S D Carson; J T Hobbs; S M Tracy; N M Chapman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.

Authors:  Jieyan Pan; Bhargavi Narayanan; Shardule Shah; Joshua D Yoder; Javier O Cifuente; Susan Hafenstein; Jeffrey M Bergelson
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

4.  Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.

Authors:  A Kühnl; C Rien; K Spengler; N Kryeziu; A Sauerbrei; R Heller; A Henke
Journal:  Med Microbiol Immunol       Date:  2014-03-11       Impact factor: 3.402

5.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.

Authors:  K U Knowlton; E S Jeon; N Berkley; R Wessely; S Huber
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.

Authors:  N Van Houten; P E Bouchard; A Moraska; S A Huber
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci.

Authors:  S A Huber; A Moraska; M Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.

Authors:  R P Loudon; A F Moraska; S A Huber; P Schwimmbeck; P Schultheiss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.

Authors:  S A Huber; J Polgar; P Schultheiss; P Schwimmbeck
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.